A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session5645be293f87695fe31ba50474913cc80980d753): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2024

img

Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2024

The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
According to MRAResearch’s new survey, global At-Home Drug of Abuse (DOA) Testing market is projected to reach US$ 862.3 million in 2033, increasing from US$ 413.2 million in 2022, with the CAGR of 10.6% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole At-Home Drug of Abuse (DOA) Testing market research.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global At-Home Drug of Abuse (DOA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Segment by Type
Test Cups
Test Dip Cards
Test Strips
Others

Segment by Application


Urine
Saliva
Hair
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The At-Home Drug of Abuse (DOA) Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Test Cups
1.2.3 Test Dip Cards
1.2.4 Test Strips
1.2.5 Others
1.3 Market by Application
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2018-2033)
2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2033)
2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2018-2023)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2022
3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2033)
6.2 North America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2018-2033)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2018-2033)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2018-2033)
9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2018-2033)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Detail
11.1.2 UCP Biosciences Business Overview
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.1.5 UCP Biosciences Recent Development
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Detail
11.2.2 Orient New Life Medical Business Overview
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.2.5 Orient New Life Medical Recent Development
11.3 Express Diagnostics Int’l
11.3.1 Express Diagnostics Int’l Company Detail
11.3.2 Express Diagnostics Int’l Business Overview
11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.3.5 Express Diagnostics Int’l Recent Development
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Detail
11.4.2 Assure Tech (Hangzhou) Business Overview
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.4.5 Assure Tech (Hangzhou) Recent Development
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Detail
11.5.2 Psychemedics Corporation Business Overview
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.5.5 Psychemedics Corporation Recent Development
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Detail
11.6.2 Confirm BioSciences Business Overview
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.6.5 Confirm BioSciences Recent Development
11.7 Phamatech
11.7.1 Phamatech Company Detail
11.7.2 Phamatech Business Overview
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.7.5 Phamatech Recent Development
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Detail
11.8.2 Home Health (U.K.) Ltd. Business Overview
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.8.5 Home Health (U.K.) Ltd. Recent Development
11.9 Quest Products
11.9.1 Quest Products Company Detail
11.9.2 Quest Products Business Overview
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
11.9.5 Quest Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Test Cups
Table 3. Key Players of Test Dip Cards
Table 4. Key Players of Test Strips
Table 5. Key Players of Others
Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2018-2023)
Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2024-2033)
Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2018-2023)
Table 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2022)
Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2023)
Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2024-2033)
Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2023)
Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2024-2033)
Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 48. UCP Biosciences Company Detail
Table 49. UCP Biosciences Business Overview
Table 50. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
Table 51. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 52. UCP Biosciences Recent Development
Table 53. Orient New Life Medical Company Detail
Table 54. Orient New Life Medical Business Overview
Table 55. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
Table 56. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 57. Orient New Life Medical Recent Development
Table 58. Express Diagnostics Int’l Company Detail
Table 59. Express Diagnostics Int’l Business Overview
Table 60. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product
Table 61. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 62. Express Diagnostics Int’l Recent Development
Table 63. Assure Tech (Hangzhou) Company Detail
Table 64. Assure Tech (Hangzhou) Business Overview
Table 65. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
Table 66. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 67. Assure Tech (Hangzhou) Recent Development
Table 68. Psychemedics Corporation Company Detail
Table 69. Psychemedics Corporation Business Overview
Table 70. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
Table 71. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 72. Psychemedics Corporation Recent Development
Table 73. Confirm BioSciences Company Detail
Table 74. Confirm BioSciences Business Overview
Table 75. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
Table 76. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 77. Confirm BioSciences Recent Development
Table 78. Phamatech Company Detail
Table 79. Phamatech Business Overview
Table 80. Phamatech At-Home Drug of Abuse (DOA) Testing Product
Table 81. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 82. Phamatech Recent Development
Table 83. Home Health (U.K.) Ltd. Company Detail
Table 84. Home Health (U.K.) Ltd. Business Overview
Table 85. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product
Table 86. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 87. Home Health (U.K.) Ltd. Recent Development
Table 88. Quest Products Company Detail
Table 89. Quest Products Business Overview
Table 90. Quest Products At-Home Drug of Abuse (DOA) Testing Product
Table 91. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2018-2023) & (US$ Million)
Table 92. Quest Products Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2022 VS 2033
Figure 3. Test Cups Features
Figure 4. Test Dip Cards Features
Figure 5. Test Strips Features
Figure 6. Others Features
Figure 7. Global At-Home Drug of Abuse (DOA) Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2022 VS 2033
Figure 9. Urine Case Studies
Figure 10. Saliva Case Studies
Figure 11. Hair Case Studies
Figure 12. Others Case Studies
Figure 13. At-Home Drug of Abuse (DOA) Testing Report Years Considered
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region: 2022 VS 2033
Figure 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2022
Figure 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2022
Figure 20. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 22. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 26. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Region (2018-2033)
Figure 34. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 42. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 46. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 49. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 50. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 51. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 52. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 53. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 54. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 55. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 56. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed